Actively Recruiting
Endoscopic Combined Intrarenal Surgery vs. Percutaneous Nephrolithotomy for Treatment of Staghorn Calculi
Led by Al-Azhar University · Updated on 2024-07-25
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective randomized study to compare endoscopic combined intrarenal surgery and PCNL as modalities of treatment for staghorn stones. In terms of efficacy and safety
CONDITIONS
Official Title
Endoscopic Combined Intrarenal Surgery vs. Percutaneous Nephrolithotomy for Treatment of Staghorn Calculi
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients are more than 18 and less than 65 years old.
- Patients with renal staghorn stones based on imaging modalities (stones occupying the renal pelvis and extending into at least 2 major calyces).
You will not qualify if you...
- Patients with renal insufficiency (serum creatinine > 1.6 mg/dl).
- Patients with active urinary tract infection.
- Patients with congenital renal anomalies.
- Morbid obesity (BMI > 35 kg/m2).
- Pregnancy.
- Bleeding Coagulopathy.
- Skeletal deformity.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al-Azhar University Hospital (New Damietta)
Damietta, Egypt, 952567
Actively Recruiting
Research Team
M
Maher Abdelrehem Mohamed, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here